Clene Inc. Clene Inc.
  • About Us
    • Leadership
    • Board of Directors
  • Science
  • Pipeline
  • Patients
    • EAP
  • Investors
    • Overview
    • Press
    • Scientific Posters & Presentations
    • Events
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Investor Resources
  • Contact
Clene Inc. Clene Inc.
  • About Us
    • Leadership
    • Board of Directors
  • Science
  • Pipeline
  • Patients
    • EAP
  • Investors
    • Overview
    • Press
    • Scientific Posters & Presentations
    • Events
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Investor Resources
  • Contact

Morgan Brown

Mr. Morgan Brown has more than 29 years of finance and accounting experience with the last twenty-two years servicing biotechnology, pharmaceutical, medical device and clinical research companies.  Prior to joining... read more →
  • December 23, 2020
  • Dianna Jensen

Mary Anne McNeil

Mary Anne McNeil is the Head of Human Resources at Clene. Ms. McNeil is an accomplished professional with a diverse and successful career in human resources, management and marketing. Prior... read more →
  • December 17, 2020
  • Dianna Jensen

Jerry Miraglia, J.D.

Mr. Miraglia has advised small private companies and large public companies, ranging from startups with only an idea to Fortune 125 companies. Most recently, he led the M&A legal team... read more →
  • December 17, 2020
  • Dianna Jensen

Michael Hotchkin

Mr. Hotchkin brings more than 20 years of experience in pharmaceutical commercialization, planning, strategy development, and medical affairs to Clene, where he currently leads commercial planning and strategy development, preclinical... read more →
  • December 17, 2020
  • Dianna Jensen

Robert Glanzman M.D., FAAN

Dr. Glanzman brings to Clene more than 20 years of industry and medical practice experience. Prior to joining the company, Dr. Glanzman served as Chief Medical Officer for GeNeuro S.A.,... read more →
  • December 17, 2020
  • Dianna Jensen

Mark Mortenson

Mr. Mortenson is the co-inventor of the technology platform developed to produce Clene’s Clean-Surface Nanocrystal (CSN™) therapeutics, as well as the inventor/co-inventor for 30 other U.S. patents and hundreds of... read more →
  • December 17, 2020
  • Dianna Jensen

Rob Etherington

Mr. Etherington brings nearly 30 years of sales, marketing and leadership experience in the pharmaceutical industry to Clene. Prior to joining Clene as CEO, Mr. Etherington worked for Actelion Pharmaceuticals,... read more →
  • December 17, 2020
  • Dianna Jensen



1-801-676-9695
info@CleneNanomedicine.com

Headquarters and Development

6550 South Millrock Drive, Suite G50
Salt Lake City, Utah 84121

Manufacturing, R&D

500 Principio Parkway West Suite 400
North East, Maryland 21901

Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2022 Clene Nanomedicine Inc. - All rights reserved